Cavitation Technologies, Inc. (CVAT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 06-30. Amounts in USD.

Revenue Quarterly

0 350K 700K 1.1M Q3 '21: 148K Q1 '22: 551K Q2 '22: 113K Q3 '22: 38K Q4 '22: 959K Q1 '23: 261K Q2 '23: 58K Q3 '23: 61K Q4 '23: 52K Q1 '24: 0 Q2 '24: 192K Q3 '24: 519K Q4 '24: 652K Q1 '25: 0 Q2 '25: 76K Q3 '25: 122K Q4 '25: 5K Q1 '26: 3K Q2 '26: 0 Q3 '26: 3K Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Gross Profit Quarterly

0 350K 700K 1.1M Q1 '21: 407K Q2 '21: 70K Q3 '21: 145K Q1 '22: 528K Q2 '22: 110K Q3 '22: 22K Q4 '22: 964K Q1 '23: 211K Q2 '23: 45K Q3 '23: 50K Q4 '23: 4K Q1 '24: 0 Q2 '24: 158K Q3 '24: 512K Q4 '24: 537K Q2 '25: 63K Q3 '25: 97K Q4 '25: 5K Q2 '26: 0 Q3 '26: 3K Q2 '21 Q2 '22 Q1 '23 Q4 '23 Q3 '24 Q3 '25 Q3 '26

Operating Income Quarterly

-600K -400K -200K 0 200K 400K 600K Q4 '21: -480K Q1 '22: 222K Q2 '22: -438K Q3 '22: -262K Q4 '22: 179K Q1 '23: -54K Q2 '23: -287K Q3 '23: -223K Q4 '23: -322K Q1 '24: -250K Q2 '24: -14K Q3 '24: 333K Q4 '24: 369K Q1 '25: -226K Q2 '25: -299K Q3 '25: -228K Q4 '25: -234K Q1 '26: -249K Q2 '26: -474K Q3 '26: -231K Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Net Income Quarterly

-1.5M -1M -500K 0 500K 1M 1.5M Q4 '21: -379K Q1 '22: 324K Q2 '22: -439K Q3 '22: -598K Q4 '22: 94K Q1 '23: -73K Q2 '23: -299K Q3 '23: -238K Q4 '23: -1.4M Q1 '24: -251K Q2 '24: -16K Q3 '24: 331K Q4 '24: 375K Q1 '25: -227K Q2 '25: 579K Q3 '25: -230K Q4 '25: -235K Q1 '26: -258K Q2 '26: -476K Q3 '26: -219K Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Cost of Revenue Quarterly

0 40K 80K 120K Q3 '21: 3K Q4 '21: 5K Q1 '22: 23K Q2 '22: 3K Q3 '22: 0 Q4 '22: 15K Q1 '23: 50K Q2 '23: 13K Q3 '23: 11K Q4 '23: 48K Q1 '24: 0 Q2 '24: 34K Q3 '24: 7K Q4 '24: 115K Q1 '25: 0 Q2 '25: 13K Q3 '25: 25K Q4 '25: 0 Q2 '26: 0 Q3 '26: 0 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q3 '26

Operating Cash Flow Quarterly

-450K -300K -150K 0 150K 300K 450K Q4 '21: -200K Q1 '22: -16K Q2 '22: 147K Q3 '22: -277K Q4 '22: -338K Q1 '23: -74K Q2 '23: -24K Q3 '23: -33K Q4 '23: -292K Q1 '24: 122K Q2 '24: -133K Q3 '24: 176K Q4 '24: 7K Q1 '25: -175K Q2 '25: -201K Q3 '25: -248K Q4 '25: -182K Q1 '26: -219K Q2 '26: -182K Q3 '26: -126K Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

Free Cash Flow Quarterly

-300K -200K -100K 0 100K 200K 300K Q3 '15: -119.2K Q4 '15: -51.5K Q3 '16: -69.8K Q4 '16: -196.2K Q3 '17: 167K Q4 '17: -17K Q3 '18: 19K Q4 '18: 65K Q3 '19: -144K Q4 '19: 94K Q1 '20: 292K Q2 '20: -204K Q3 '20: 97K Q4 '20: -179K Q1 '21: -187K Q2 '21: 170K Q3 '21: -158K Q4 '21: -203K Q1 '22: -266K Q1 '23: -74K Q4 '15 Q3 '17 Q4 '18 Q1 '20 Q4 '20 Q3 '21 Q1 '23

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 150M 300M 450M Q2 '15: 184.2M Q3 '15: 184.2M Q1 '16: 198.8M Q1 '17: 194M Q3 '21: 197M Q1 '22: 218.9M Q2 '22: 232.7M Q3 '22: 268.6M Q1 '23: 276.7M Q2 '23: 276.7M Q3 '23: 277.8M Q1 '24: 284.3M Q2 '24: 284.3M Q3 '24: 284.3M Q1 '25: 284.3M Q2 '25: 284.3M Q3 '25: 286.5M Q1 '26: 289.2M Q2 '26: 301.2M Q3 '26: 309.7M Q3 '15 Q3 '21 Q3 '22 Q3 '23 Q3 '24 Q3 '25 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.01 -0.01 -0.00 0.00 0.00 0.01 0.01 Q4 '21: 0.00 Q1 '22: 0.00 Q2 '22: 0.00 Q3 '22: 0.00 Q4 '22: 0.00 Q1 '23: 0.00 Q2 '23: 0.00 Q3 '23: 0.00 Q4 '23: -0.01 Q1 '24: -0.01 Q2 '24: -0.01 Q3 '24: -0.01 Q4 '24: 0.00 Q1 '25: 0.00 Q2 '25: 0.00 Q3 '25: 0.00 Q4 '25: 0.00 Q1 '26: 0.00 Q2 '26: 0.00 Q3 '26: 0.00 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25 Q3 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.